The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.
Also called NCT06471699
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 250 participants
- Registry
-
NCT06471699
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06471699. Randomized; no masking; primary purpose supportive care. Start 2024-11-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes
- Acronym
- CHANGE-diab
- Condition
- Diabetes Type 2
- Intervention (Device)
- Continous Glucose Monitoring
- Intervention (Other)
- Self monitoring blood glucose
- Lead sponsor
- Vastra Gotaland Region
- Collaborator
- The Swedish Research Council
- Collaborator
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct06471699- Content hash
d2070245df261d9167a9ddac83a1422c39373dc3f81e278d54a15ef07e0f7a8d